Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
22622 | 319 | 37.0 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
277 | 18434 | STROKE//INTRACEREBRAL HEMORRHAGE//ACUTE STROKE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ABNORMAL BLOOD LIPIDS | Author keyword | 1 | 50% | 0% | 1 |
2 | BEYIN CERRAHI SERV | Address | 1 | 50% | 0% | 1 |
3 | BRAIN INJURY GRP BIOMED | Address | 1 | 50% | 0% | 1 |
4 | CIENCIAS MED FARMACOL | Address | 1 | 50% | 0% | 1 |
5 | COMPREHENS STROKE VASC NEUROL PROGRAM | Address | 1 | 50% | 0% | 1 |
6 | EQUIPE RECH PHARMACOL CIRCULAT CEREBRALE EA 2510 | Address | 1 | 50% | 0% | 1 |
7 | HYDROXYMETHYLGLUTARYL COA HMG COA | Author keyword | 1 | 50% | 0% | 1 |
8 | NEUROL GERIATR KLIN | Address | 1 | 50% | 0% | 1 |
9 | NEUROL NEPHROL RHEMATOL | Address | 1 | 50% | 0% | 1 |
10 | NEUROVASC UNIT PL TRANSLAT THER EUT | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ABNORMAL BLOOD LIPIDS | 1 | 50% | 0% | 1 | Search ABNORMAL+BLOOD+LIPIDS | Search ABNORMAL+BLOOD+LIPIDS |
2 | HYDROXYMETHYLGLUTARYL COA HMG COA | 1 | 50% | 0% | 1 | Search HYDROXYMETHYLGLUTARYL+COA+HMG+COA | Search HYDROXYMETHYLGLUTARYL+COA+HMG+COA |
3 | SPLEEN QI DEFICIENCY | 1 | 50% | 0% | 1 | Search SPLEEN+QI+DEFICIENCY | Search SPLEEN+QI+DEFICIENCY |
4 | AXONAL COUNTS | 0 | 33% | 0% | 1 | Search AXONAL+COUNTS | Search AXONAL+COUNTS |
5 | NMPA | 0 | 33% | 0% | 1 | Search NMPA | Search NMPA |
6 | PERCUTANEOUS EMBOLECTOMY | 0 | 33% | 0% | 1 | Search PERCUTANEOUS+EMBOLECTOMY | Search PERCUTANEOUS+EMBOLECTOMY |
7 | STROKE CARE UNIT | 0 | 33% | 0% | 1 | Search STROKE+CARE+UNIT | Search STROKE+CARE+UNIT |
8 | EMBOLIC CEREBRAL ISCHEMIA | 0 | 25% | 0% | 1 | Search EMBOLIC+CEREBRAL+ISCHEMIA | Search EMBOLIC+CEREBRAL+ISCHEMIA |
9 | LIPID LOWERING MEDICATION | 0 | 25% | 0% | 1 | Search LIPID+LOWERING+MEDICATION | Search LIPID+LOWERING+MEDICATION |
10 | LUMBAR SPINE INJURY | 0 | 25% | 0% | 1 | Search LUMBAR+SPINE+INJURY | Search LUMBAR+SPINE+INJURY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REDUCES NEUROLOGICAL DEFICIT | 3 | 60% | 1% | 3 |
2 | PRIOR STATIN USE | 2 | 29% | 2% | 7 |
3 | ATORVASTATIN REDUCTION | 2 | 67% | 1% | 2 |
4 | MORPHOLOGICAL CONSEQUENCES | 2 | 26% | 2% | 6 |
5 | STROKE PROTECTION | 1 | 18% | 2% | 7 |
6 | ABDOMINAL AORTA OCCLUSION | 1 | 50% | 0% | 1 |
7 | CEREBRAL INFARCT VOLUME | 1 | 50% | 0% | 1 |
8 | EXTENDED RELEASE ASPIRIN | 1 | 50% | 0% | 1 |
9 | PROTEASOME INHIBITOR PS 519 | 1 | 50% | 0% | 1 |
10 | RATING SCORES | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Statin Therapy and Outcome After Ischemic Stroke Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials | 2013 | 17 | 57 | 65% |
Systematic review and meta-analysis of the efficacy of statins in experimental stroke | 2012 | 10 | 38 | 50% |
Statin use and lipid profile in relation to safety and functional outcome after thrombolysis in ischemic stroke | 2012 | 1 | 20 | 90% |
Outcomes after thrombolysis in AIS according to prior statin use A registry and review | 2012 | 4 | 26 | 62% |
Neuroprotection by pravastatin in acute ischemic stroke in rats | 2008 | 32 | 23 | 35% |
Statins in Traumatic Brain Injury | 2010 | 21 | 86 | 27% |
Evidence for the efficacy of statins in animal stroke models: a meta-analysis | 2012 | 13 | 35 | 29% |
The Atorvastatin During Ischemic Stroke Study: A Pilot Randomized Controlled Trial | 2011 | 4 | 31 | 48% |
Pre-stroke use of statins on stroke outcome: a meta-analysis of observational studies | 2011 | 4 | 30 | 47% |
Statins for acute ischemic stroke | 2011 | 5 | 20 | 40% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BEYIN CERRAHI SERV | 1 | 50% | 0.3% | 1 |
2 | BRAIN INJURY GRP BIOMED | 1 | 50% | 0.3% | 1 |
3 | CIENCIAS MED FARMACOL | 1 | 50% | 0.3% | 1 |
4 | COMPREHENS STROKE VASC NEUROL PROGRAM | 1 | 50% | 0.3% | 1 |
5 | EQUIPE RECH PHARMACOL CIRCULAT CEREBRALE EA 2510 | 1 | 50% | 0.3% | 1 |
6 | NEUROL GERIATR KLIN | 1 | 50% | 0.3% | 1 |
7 | NEUROL NEPHROL RHEMATOL | 1 | 50% | 0.3% | 1 |
8 | NEUROVASC UNIT PL TRANSLAT THER EUT | 1 | 50% | 0.3% | 1 |
9 | NEW YORK P BYTERIAN HOSP CARDIOL | 1 | 50% | 0.3% | 1 |
10 | OSPED S CORONA | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000199081 | FLUVASTATIN//PLEIOTROPIC EFFECTS//HMG COA REDUCTASE INHIBITOR |
2 | 0.0000147378 | 24S HYDROXYCHOLESTEROL//CYP46//24 HYDROXYCHOLESTEROL |
3 | 0.0000119828 | P DIS TB INTERNAL MED//3 HYDROXY 3 METHYLGLUTARYL CO ENZYME A REDUCTASE INHIBITOR//INTER PROGRAM IMMUNOL |
4 | 0.0000113189 | TRANSIENT ISCHEMIC ATTACK//ABCD2 SCORE//TIA |
5 | 0.0000108060 | STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN |
6 | 0.0000091238 | TRIFLUSAL//HTB//CAS 322 79 2 |
7 | 0.0000078918 | THROMBOLYSIS//ACUTE ISCHEMIC STROKE//ACUTE STROKE |
8 | 0.0000068256 | CASE FATALITY//STROKE INCIDENCE//STROKE EPIDEMIOLOGY |
9 | 0.0000067860 | ISCHEMIC TOLERANCE//NMDA PRECONDITIONING//CHEMICAL PRECONDITIONING |
10 | 0.0000066630 | INTRACEREBRAL HEMORRHAGE//HEMATOMA EXPANSION//SPOT SIGN |